| Net sales | 1.39B |
| Cost of sales | 1.26B |
| Gross profit | 137.81M |
| Selling, general & administrative expenses | 140.39M |
| Research and development expenses | 11.16M |
| Royalty expense | 10.53M |
| Income from operations | -24.28M |
| Interest expense | -34.03M |
| Noncash convertible debt conversion charge | 0 |
| Loss on senior note repurchase | 0 |
| Other income (expense) | 11.06M |
| Income before income taxes | -52.01M |
| Provision for income taxes | 38.28M |
| Net Income | -90.29M |
| Net (loss) attributable to noncontrolling interests | 14.65M |
| Net income attributable to Titan | -75.63M |
| Basic (in dollars per share) | -1.74 |
| Diluted (in dollars per share) | -1.74 |
| Basic (in shares) | 53.7M |
| Diluted (in shares) | 53.7M |
| Dividends declared per common share: | 0.02 |